News & Press Releases
Filter by:
Mintz served as health regulatory counsel to LucyRx, a technology-enabled pharmacy benefit manager (PBM), in its strategic combination with Abarca Health, creating a modern, independent PBM designed to serve commercial and government clients at scale.
Mintz advised the underwriters in connection with MoonLake Immunotherapeutics’ $200 million public offering of Class A ordinary shares.
Seven Years of Impact: Mintz Receives 2026 NLADA Beacon of Justice Award for Protecting Democracy and Civil Society
June 25, 2026
Mintz will receive a 2026 Beacon of Justice Award from the National Legal Aid & Defender Association (NLADA) in recognition of the firm’s efforts to protect democracy and civil society, marking the seventh consecutive year Mintz has been honored with this award.
Mintz served as legal counsel to Innovius Capital Management in connection with its role as lead investor in the $46 million Series B financing of xCures, an Oakland-based digital health company developing AI-driven solutions for medical record acquisition and analysis.
Mintz Advises on uniQure’s $259 Million Public Offering
June 25, 2026
Mintz advised the underwriters in connection with uniQure’s $259 million public offering of ordinary shares.
'We Got It Wrong': Mass. Top Court Throws Out Rent Control Initiative in Latest Election Ballot Ruling
June 24, 2026
Elissa Flynn-Poppey and Edmund Daley were featured in a Law.com article about a significant victory they secured before the Massachusetts Supreme Judicial Court, which ruled that a proposed statewide rent control ballot initiative could not appear on the November ballot. The court held that the measure violated Article 48 of the Massachusetts Constitution because it made religion a factor in the law’s application by including an exemption for facilities that are operated solely for religious purposes.

